Last update 11 Mar 2025

HSK-44459

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HSK44459
Target
PDE4B
Mechanism
PDE4B inhibitors(Phosphodiesterase 4B inhibitors)
Therapeutic Areas
Cardiovascular DiseasesCongenital DisordersEye Diseases+ [5]
Active Indication
Behcet SyndromeIdiopathic Pulmonary FibrosisDermatitis, Atopic+ [1]
Inactive Indication-
Originator Organization
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.
Active Organization
Shanghai Haisishengnuo Pharmaceutical Technology Co., LtdHaisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.Sichuan Haisco Pharmaceutical Co., Ltd.Sichuan Haisco Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with HSK-44459
NCT06764862
/ Not yet recruitingPhase 2
A Randomised, Double-blind, Placebo-controlled Parallel Group Phase II Clinical Study Evaluating the Efficacy and Safety of HSK44459 Tablets in Subjects With Idiopathic Pulmonary Fibrosis
CTR20250017
/ RecruitingPhase 2
一项评价HSK44459片用于特发性肺纤维化受试者的有效性及安全性的多中心、随机、双盲、安慰剂对照的Ⅱ期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of HSK44459 tablets in subjects with idiopathic pulmonary fibrosis
NCT06858657
/ CompletedPhase 1
A Single and Multiple Ascending Dose Study to Assess the Safety,Tolerability, PK,PD and Food Effect of HSK44459 in Healthy Subjects
100 Clinical Results associated with HSK-44459
Login to view more data
100 Translational Medicine associated with HSK-44459
Login to view more data
100 Patents (Medical) associated with HSK-44459
Login to view more data
100 Deals associated with HSK-44459
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Behcet SyndromePhase 2
CN
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.
10 Mar 2025
Idiopathic Pulmonary FibrosisPhase 2
CN
Sichuan Haisco Pharmaceutical Co., Ltd.Sichuan Haisco Pharmaceutical Co., Ltd.
17 Jan 2025
Dermatitis, AtopicIND Approval
CN
Shanghai Haisishengnuo Pharmaceutical Technology Co., Ltd
11 Mar 2025
PsoriasisIND Approval
CN
Shanghai Haisishengnuo Pharmaceutical Technology Co., Ltd
11 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free